Search research articles
Contact Us
Filters
Showing results (21-30 of 117) with videos related to
Page
of 12
Sort By:
Experimental Hematology
|
August 1, 1996
Isolation of primitive human bone marrow hematopoietic progenitor cells using Hoechst 33342 and Rhodamine 123
T Leemhuis, M C Yoder, S Grigsby, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Influence of scheduling on two-drug combinations of alkylating agents in vivo
B A Teicher, S A Holden, S M Jones, et al.
Cancer Treatment Reports
|
July 1, 1986
Pharmacokinetics and immediate effects of high-dose carmustine in man
W D Henner, W P Peters, J P Eder, et al.
The Journal of Clinical Investigation
|
May 1, 1987
Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model
J P Eder, B A Teicher, S A Holden, et al.
Thyroid : Official Journal of the American Thyroid Association
|
November 11, 2005
Interobserver variation for ultrasound determination of thyroid nodule volumes
V F H Brauer, P Eder, K Miehle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1990
High-dose ifosfamide with mesna uroprotection: a phase I study
A D Elias, J P Eder, T Shea, et al.
Sportverletzung Sportschaden : Organ Der Gesellschaft Fur Orthopadisch-Traumatologische Sportmedizin
|
March 15, 2011
[Development and evaluation of a soccer focused complexity test]
R Schwesig, M Darmochwal, T Diedrich, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Ability of four potential topoisomerase II inhibitors to enhance the cytotoxicity of cis-diamminedichloroplatinum (II) in Chinese hamster ovary cells and in an epipodophyllotoxin-resistant subline
J P Eder, B A Teicher, S A Holden, et al.
Cancer Research
|
November 1, 1989
Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo
B A Teicher, S A Holden, J P Eder, et al.
Cancer Research
|
February 1, 1989
Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents
J P Eder, B A Teicher, S A Holden, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 117) with videos related to
Sort By:
Page
of 12
Experimental Hematology
|
August 1, 1996
Isolation of primitive human bone marrow hematopoietic progenitor cells using Hoechst 33342 and Rhodamine 123
T Leemhuis, M C Yoder, S Grigsby, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Influence of scheduling on two-drug combinations of alkylating agents in vivo
B A Teicher, S A Holden, S M Jones, et al.
Cancer Treatment Reports
|
July 1, 1986
Pharmacokinetics and immediate effects of high-dose carmustine in man
W D Henner, W P Peters, J P Eder, et al.
The Journal of Clinical Investigation
|
May 1, 1987
Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model
J P Eder, B A Teicher, S A Holden, et al.
Thyroid : Official Journal of the American Thyroid Association
|
November 11, 2005
Interobserver variation for ultrasound determination of thyroid nodule volumes
V F H Brauer, P Eder, K Miehle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1990
High-dose ifosfamide with mesna uroprotection: a phase I study
A D Elias, J P Eder, T Shea, et al.
Sportverletzung Sportschaden : Organ Der Gesellschaft Fur Orthopadisch-Traumatologische Sportmedizin
|
March 15, 2011
[Development and evaluation of a soccer focused complexity test]
R Schwesig, M Darmochwal, T Diedrich, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Ability of four potential topoisomerase II inhibitors to enhance the cytotoxicity of cis-diamminedichloroplatinum (II) in Chinese hamster ovary cells and in an epipodophyllotoxin-resistant subline
J P Eder, B A Teicher, S A Holden, et al.
Cancer Research
|
November 1, 1989
Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo
B A Teicher, S A Holden, J P Eder, et al.
Cancer Research
|
February 1, 1989
Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents
J P Eder, B A Teicher, S A Holden, et al.
Page
of 12